AustralieFrV1, PubMed, Corpus, bibRecord, 000036

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Identifieur interne : 000036 ( PubMed/Corpus ); précédent : 000035; suivant : 000037

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Auteurs : Nicolas Mottet ; Maria De Santis ; Erik Briers ; Silke Gillessen ; Jeremy P. Grummet ; Thomas B. Lam ; Henk G. Van Der Poel ; Olivier Rouvière ; Roderick C. Van Den Bergh ; Philip Cornford

Source :

European urology [ 1873-7560 ] ; 2017.

RBID : pubmed:29103760

Abstract

Addition of docetaxel to androgen deprivation therapy (ADT) was recommended for patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), who are fit enough to receive docetaxel. Two recently published trials showed that the addition of abiraterone acetate plus prednisone to ADT has a clear survival benefit and acceptable overall tolerance, and should be considered as another standard of care for newly diagnosed mHSPC.

DOI: 10.1016/j.eururo.2017.09.029
PubMed: 29103760

Links to Exploration step

pubmed:29103760

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.</title>
<author><name sortKey="Mottet, Nicolas" sort="Mottet, Nicolas" uniqKey="Mottet N" first="Nicolas" last="Mottet">Nicolas Mottet</name>
<affiliation><nlm:affiliation>Department of Urology, University Hospital, St. Etienne, France. Electronic address: nicolas.mottet@chu-st-etienne.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Santis, Maria" sort="De Santis, Maria" uniqKey="De Santis M" first="Maria" last="De Santis">Maria De Santis</name>
<affiliation><nlm:affiliation>Clinical Trials Unit, University of Warwick, UK; Department of Urology, Medical University of Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Briers, Erik" sort="Briers, Erik" uniqKey="Briers E" first="Erik" last="Briers">Erik Briers</name>
<affiliation><nlm:affiliation>Patient Advocate, Hasselt, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gillessen, Silke" sort="Gillessen, Silke" uniqKey="Gillessen S" first="Silke" last="Gillessen">Silke Gillessen</name>
<affiliation><nlm:affiliation>Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; University of Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grummet, Jeremy P" sort="Grummet, Jeremy P" uniqKey="Grummet J" first="Jeremy P" last="Grummet">Jeremy P. Grummet</name>
<affiliation><nlm:affiliation>Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lam, Thomas B" sort="Lam, Thomas B" uniqKey="Lam T" first="Thomas B" last="Lam">Thomas B. Lam</name>
<affiliation><nlm:affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Der Poel, Henk G" sort="Van Der Poel, Henk G" uniqKey="Van Der Poel H" first="Henk G" last="Van Der Poel">Henk G. Van Der Poel</name>
<affiliation><nlm:affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rouviere, Olivier" sort="Rouviere, Olivier" uniqKey="Rouviere O" first="Olivier" last="Rouvière">Olivier Rouvière</name>
<affiliation><nlm:affiliation>Hospices Civils de Lyon, Radiology Department, Edouard Herriot Hospital, Lyon, France; Université de Lyon; Université Lyon 1, Faculté de médecine Lyon Est, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Den Bergh, Roderick C" sort="Van Den Bergh, Roderick C" uniqKey="Van Den Bergh R" first="Roderick C" last="Van Den Bergh">Roderick C. Van Den Bergh</name>
<affiliation><nlm:affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cornford, Philip" sort="Cornford, Philip" uniqKey="Cornford P" first="Philip" last="Cornford">Philip Cornford</name>
<affiliation><nlm:affiliation>Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29103760</idno>
<idno type="pmid">29103760</idno>
<idno type="doi">10.1016/j.eururo.2017.09.029</idno>
<idno type="wicri:Area/PubMed/Corpus">000036</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000036</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.</title>
<author><name sortKey="Mottet, Nicolas" sort="Mottet, Nicolas" uniqKey="Mottet N" first="Nicolas" last="Mottet">Nicolas Mottet</name>
<affiliation><nlm:affiliation>Department of Urology, University Hospital, St. Etienne, France. Electronic address: nicolas.mottet@chu-st-etienne.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="De Santis, Maria" sort="De Santis, Maria" uniqKey="De Santis M" first="Maria" last="De Santis">Maria De Santis</name>
<affiliation><nlm:affiliation>Clinical Trials Unit, University of Warwick, UK; Department of Urology, Medical University of Vienna, Austria.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Briers, Erik" sort="Briers, Erik" uniqKey="Briers E" first="Erik" last="Briers">Erik Briers</name>
<affiliation><nlm:affiliation>Patient Advocate, Hasselt, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gillessen, Silke" sort="Gillessen, Silke" uniqKey="Gillessen S" first="Silke" last="Gillessen">Silke Gillessen</name>
<affiliation><nlm:affiliation>Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; University of Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Grummet, Jeremy P" sort="Grummet, Jeremy P" uniqKey="Grummet J" first="Jeremy P" last="Grummet">Jeremy P. Grummet</name>
<affiliation><nlm:affiliation>Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lam, Thomas B" sort="Lam, Thomas B" uniqKey="Lam T" first="Thomas B" last="Lam">Thomas B. Lam</name>
<affiliation><nlm:affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Der Poel, Henk G" sort="Van Der Poel, Henk G" uniqKey="Van Der Poel H" first="Henk G" last="Van Der Poel">Henk G. Van Der Poel</name>
<affiliation><nlm:affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rouviere, Olivier" sort="Rouviere, Olivier" uniqKey="Rouviere O" first="Olivier" last="Rouvière">Olivier Rouvière</name>
<affiliation><nlm:affiliation>Hospices Civils de Lyon, Radiology Department, Edouard Herriot Hospital, Lyon, France; Université de Lyon; Université Lyon 1, Faculté de médecine Lyon Est, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Van Den Bergh, Roderick C" sort="Van Den Bergh, Roderick C" uniqKey="Van Den Bergh R" first="Roderick C" last="Van Den Bergh">Roderick C. Van Den Bergh</name>
<affiliation><nlm:affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cornford, Philip" sort="Cornford, Philip" uniqKey="Cornford P" first="Philip" last="Cornford">Philip Cornford</name>
<affiliation><nlm:affiliation>Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">European urology</title>
<idno type="eISSN">1873-7560</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Addition of docetaxel to androgen deprivation therapy (ADT) was recommended for patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), who are fit enough to receive docetaxel. Two recently published trials showed that the addition of abiraterone acetate plus prednisone to ADT has a clear survival benefit and acceptable overall tolerance, and should be considered as another standard of care for newly diagnosed mHSPC.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">29103760</PMID>
<DateCreated><Year>2017</Year>
<Month>11</Month>
<Day>06</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>11</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7560</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year>
<Month>Nov</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>European urology</Title>
<ISOAbbreviation>Eur. Urol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">S0302-2838(17)30839-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eururo.2017.09.029</ELocationID>
<Abstract><AbstractText>Addition of docetaxel to androgen deprivation therapy (ADT) was recommended for patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), who are fit enough to receive docetaxel. Two recently published trials showed that the addition of abiraterone acetate plus prednisone to ADT has a clear survival benefit and acceptable overall tolerance, and should be considered as another standard of care for newly diagnosed mHSPC.</AbstractText>
<CopyrightInformation>Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mottet</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Urology, University Hospital, St. Etienne, France. Electronic address: nicolas.mottet@chu-st-etienne.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>De Santis</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Clinical Trials Unit, University of Warwick, UK; Department of Urology, Medical University of Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Briers</LastName>
<ForeName>Erik</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Patient Advocate, Hasselt, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gillessen</LastName>
<ForeName>Silke</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Oncology/Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; University of Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grummet</LastName>
<ForeName>Jeremy P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Department of Surgery, Central Clinical School, Monash University, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lam</LastName>
<ForeName>Thomas B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo><Affiliation>Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van der Poel</LastName>
<ForeName>Henk G</ForeName>
<Initials>HG</Initials>
<AffiliationInfo><Affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rouvière</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Hospices Civils de Lyon, Radiology Department, Edouard Herriot Hospital, Lyon, France; Université de Lyon; Université Lyon 1, Faculté de médecine Lyon Est, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van den Bergh</LastName>
<ForeName>Roderick C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo><Affiliation>Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cornford</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>11</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Eur Urol</MedlineTA>
<NlmUniqueID>7512719</NlmUniqueID>
<ISSNLinking>0302-2838</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>09</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>09</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>11</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29103760</ArticleId>
<ArticleId IdType="pii">S0302-2838(17)30839-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.eururo.2017.09.029</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000036 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000036 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:29103760
   |texte=   Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:29103760" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki